Therefore, it can be hypothesized that TRPA1 plays an important role in forming COVID-19-associated myocardial fibrosis, which provides a potential drug target for treating COVID-19-associated myocardial fibrosis. The gene discussed is TRPA1; the disease is Myocardial fibrosis.